Safety Study of Syntropin (Human Growth Hormone) for the Treatment of Growth Hormone Deficiency

NCT00489294 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Growth Hormone Deficiency

Interventions

DRUG: Syntropin

Sponsor

Phage Pharmaceuticals, Inc.